Company registration number 09759479 (England and Wales)
QUANTESSENCE TECHNOLOGY LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
QUANTESSENCE TECHNOLOGY LIMITED
COMPANY INFORMATION
Directors
Peter De Clercq
Wim Hautekiet
Company number
09759479 (England and Wales)
Registered office
33 Cannon Street
2nd Floor
London
EC4M 5SB
Auditor
MHA
Lyndean House
30-32 Albion Place
Maidstone
Kent
ME14 5DZ
QUANTESSENCE TECHNOLOGY LIMITED
CONTENTS
Page
Directors' report
1 - 2
Independent auditor's report
4 - 7
Statement of comprehensive income
6
Statement of financial position
7
Statement of changes in equity
8
Statement of cash flows
9
Notes to the financial statements
10 - 16
QUANTESSENCE TECHNOLOGY LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024
- 1 -

The directors present their annual report and financial statements for the year ended 31 December 2024.

Principal activities

The principal activity of the Company continued to be that of the ringfencing of the Quantessence software.

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

Peter De Clercq
Wim Hautekiet
Nikolaos Papadopoulos
(Resigned 30 November 2024)
REVIEW OF BUSINESS AND RISK ANALYSIS
Liquidity Risk

Quantessence Technology Limited has no significant debts or liquidity position. The directors are comfortable that any liquidity risk the Company may face in the next twelve months is mitigated by the continuous financial support provided by Quantessence Limited.

Market Risk

Quantessence Technology Limited does not currently consider itself exposed to market risks as its activities are not related to financial markets and it holds no quoted investments.

Credit Risk

Quantessence Technology Limited's credit risk is deemed marginal as debtor balances only relate to intercompany transactions.

Foreign Exchange Risk

The Company's revenues and costs are GBP denominated, hence there is no noteworthy Foreign Exchange risk.

 

 

QUANTESSENCE TECHNOLOGY LIMITED
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 2 -
Statement of directors' responsibilities

The directors are responsible for preparing the directors' report and the financial statements in accordance with applicable law and regulations.

 

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with International Financial Reporting Standards (IFRSs) in conformity with the Companies Act 2006. Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Company and of the profit or loss of the Company for that period.

 

In preparing these financial statements, the directors are required to:

 

 

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the Company’s transactions and disclose with reasonable accuracy at any time the financial position of the Company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the Company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Statement of disclosure to auditor

Each director in office at the date of approval of this annual report confirms that:

Auditor

The auditor, MHA Audit Services LLP, is deemed to be reappointed under section 487(2) of the Companies Act 2006.

This confirmation is given and should be interpreted in accordance with the provisions of section 418 of the Companies Act 2006.
This report was approved and signed by the board on its behalf by:
Peter De Clercq
Director
18 December 2025
QUANTESSENCE TECHNOLOGY LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF QUANTESSENCE TECHNOLOGY LIMITED
- 3 -
Opinion on the financial statements

 

We have audited the financial statements of Quantessence Technology Limited (“the Company”) for the year ended 31 December 2024 which comprise the Statement of Comprehensive Income, the Statement of Financial Position, the Statement of Changes in Equity, the Statement of Cash Flows and the related notes including a summary of the significant accounting policies set out on pages 10 - 16. The financial reporting framework that has been applied in their preparation is applicable law and International Financial Reporting Standards (IFRSs) as adopted by the United Kingdom.

 

In our opinion the financial statements:

 

Basis for opinion

 

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor’s responsibilities for the audit of the financial statements section of our report. We are independent of the Company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the Financial Reporting Council’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

 

In auditing the financial statements, we have concluded that the directors’ use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

 

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Company’s ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

 

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

 

The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. The directors are responsible for the other information.

 

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

 

Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

 

QUANTESSENCE TECHNOLOGY LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF QUANTESSENCE TECHNOLOGY LIMITED
- 4 -

Opinions on other matters prescribed by the Companies Act 2006

 

In our opinion, based on the work undertaken in the course of the audit:

 

Matters on which we are required to report by exception

 

In the light of the knowledge and understanding of the Company and its environment obtained in the course of the audit, we have not identified material misstatements in the Directors’ report.

 

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

 

 

 

 

Responsibilities of Directors

 

As explained more fully in the Statement of directors responsibilities, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

 

In preparing the financial statements, the directors are responsible for assessing the Company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the Company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

 

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The specific procedures for this engagement and the extent to which these are capable of detecting irregularities, including fraud is detailed below:

QUANTESSENCE TECHNOLOGY LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF QUANTESSENCE TECHNOLOGY LIMITED
- 5 -

 

 

 

 

 

Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.

A further description of our responsibilities for the financial statements is located on the FRC’s website at: www.frc.org.uk/auditorsresponsibilities . This description forms part of our auditor’s report.

Use of our report

 

This report is made solely to the Company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the Company’s members those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company and the Company’s members as a body, for our audit work, for this report, or for the opinions we have formed.

 

 

Duncan Cochrane-Dyet BSc BFP FCA (Senior Statutory Auditor)
For and on behalf of MHA, Statutory Auditor
Maidstone
United Kingdom
24 December 2025
MHA is the trading name of MHA Audit Services LLP, a limited liability partnership in England and Wales (registered number OC455542).
QUANTESSENCE TECHNOLOGY LIMITED
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2024
- 6 -
2024
2023
Notes
£
£
Revenue
4
31,589
28,563
Gross profit
31,589
28,563
Administrative expenses
(23,422)
(38,996)
Operating profit/(loss)
8,167
(10,433)
Finance income
7
2
-
0
Finance costs
7
(3,061)
(1,678)
Profit/(loss) before taxation
5,108
(12,111)
Income tax expense
8
-
-
Profit/(loss) for the year
5,108
(12,111)
Other comprehensive income:
-
0
-
0
Total comprehensive income for the year
5,108
(12,111)

The income statement has been prepared on the basis that all operations are continuing operations.

The notes on pages 10 to 16 form part of these financial statements.
QUANTESSENCE TECHNOLOGY LIMITED
STATEMENT OF FINANCIAL POSITION
AS AT
31 DECEMBER 2024
31 December 2024
- 7 -
2024
2023
Notes
£
£
Non-current assets
Other receivables
9
1
1
Current assets
Trade and other receivables
9
71,627
33,987
Cash and cash equivalents
9,549
7,968
81,176
41,955
Total assets
81,177
41,956
Current liabilities
Trade and other payables
10
127,939
93,826
Net current liabilities
(46,763)
(51,871)
Total liabilities
127,939
93,826
Net liabilities
(46,762)
(51,870)
Equity
Called up share capital
11
2
2
Share premium account
12
179,999
179,999
Retained earnings
(226,763)
(231,871)
Total equity
(46,762)
(51,870)
The notes on pages 10 to 16 form part of these financial statements.
The financial statements were approved by the board of directors and authorised for issue on 18 December 2025 and are signed on its behalf by:
Peter De Clercq
Director
Company Registration No. 09759479
QUANTESSENCE TECHNOLOGY LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2024
- 8 -
Share capital
Share premium account
Retained earnings
Total
£
£
£
£
Balance at 1 January 2023
2
179,999
(219,760)
(39,759)
Year ended 31 December 2023:
Loss and total comprehensive income for the year
-
-
(12,111)
(12,111)
Balance at 31 December 2023
2
179,999
(231,871)
(51,870)
Year ended 31 December 2024:
Loss and total comprehensive income for the year
-
-
5,108
5,108
Balances at 31 December 2024
2
179,999
(226,763)
(46,762)
The notes on pages 10 to 16 form part of these financial statements.
QUANTESSENCE TECHNOLOGY LIMITED
STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 9 -
2024
2023
Notes
£
£
Net cash inflow from operating activities
15
1,579
5,589
Investing activities
Interest received
2
-
0
Net cash generated from investing activities
2
-
0
Net increase in cash and cash equivalents
1,581
5,589
Cash and cash equivalents at beginning of year
7,968
2,379
Cash and cash equivalents at end of year
9,549
7,968
The notes on pages 10 to 16 form part of these financial statements.
QUANTESSENCE TECHNOLOGY LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 10 -
1
Accounting policies
Company information

Quantessence Technology Limited is a private company limited by shares incorporated in England and Wales. The registered office is 33 Cannon Street, 2nd Floor, London, England, EC4M 5SB. The Company's principal activities and nature of its operations are disclosed in the directors' report.

1.1
Accounting convention

The financial statements have been prepared in accordance with international accounting standards in conformity with the requirements of the Companies Act 2006.

 

The preparation of financial statements in conformity with IFRSs requires the use of certain critical accounting estimates. It also requires management to exercise its judgement in the process of applying the Company's accounting policies. The areas involving a degree of judgement or complexity or areas where assumptions or estimates are significant to the financials are noted in the critical judgements accounting policy note.

Functional and presentational currency

The financial statements are prepared in sterling, which is the functional currency of the Company. Monetary amounts in these financial statements are rounded to the nearest £.

Basis of preparation of financial statements

The financial statements have been prepared on the historical cost basis. The principal accounting policies adopted are set out below.

1.2
Going concern

The Company is supported by its UK holding company, Quantessence Limited, which has confiirmed its support for a period of at least 12 months from the date of approval of these accounts. Quantessence Limited in turn has received a letter of support from its ultimate parent undertaking Euroclear SA similarly giving support for the same period. On this basis the directors are of the opinion that the Company has adequate resources to enable it to undertake its planned activities over the next twelve months from the signing of the financial statements.true

1.3
Revenue

Revenue comprises the fair value of consideration received or receivable for the sale of services in the ordinary course of the company's activities. Fee income represents a return for services rendered and is recognised when the service is performed. All revenue is derived from the UK .

1.4
Cash and cash equivalents

Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.5
Financial assets

Financial assets are recognised in the Company's statement of financial position when the company becomes party to the contractual provisions of the instrument. Financial assets and liabilities are offset with the net presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is intention to settle on a net basis or to realise the asset and settle the liability simultaneously. The Company has financial assets primarily in the form of trade and other receivables and cash and cash equivalents. These assets are non-derivative financial assets with fixed or determinable payments that are not quoted in an active market.

 

Loans and receivables are non-derivative financial assets with fixed or determinable payments that are not quoted in an active market. They are initially recognised in the balance sheet on settlement date at fair value plus directly related transaction costs, if any, when cash is advanced to the borrowers, They are subsequently measured at amortised costs using the effective interest method.

QUANTESSENCE TECHNOLOGY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 11 -
1.6
Financial liabilities

The company has financial liabilities primarily in the form of trade and other payables. These liabilities are non-derivative financial liabilities with fixed or determinable payments that are not quoted in an active market.

 

Basic financial liabilities including loans from fellow group companies that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes as financing transaction where the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest.

 

Trade payables are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade payables are recognised initially at transaction price and subsequently measured at amortised cost.

 

Borrowings are initially measured at fair value, being the issued proceeds (fair value of consideration received) net of transaction costs incurred. Borrowings are subsequently measured at amortised cost; any difference between proceeds net of transaction costs and the redemption value is recognised in the income statement over the period of the borrowings using the effective interest rate method.

1.7
Equity instruments

Equity instruments issued by the Company are recorded at the proceeds received, net of direct issue costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the Company.

1.8
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax is the tax expected to be payable or recoverable on differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit, and is accounted for using the balance sheet liability method. Deferred tax liabilities are generally recognised for all taxable temporary differences and deferred tax assets are recognised to the extent that it is probable that taxable profits will be available against which deductible temporary differences can be utilised. Such assets and liabilities are not recognised if the temporary difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the income statement, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

QUANTESSENCE TECHNOLOGY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 12 -
1.9
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

1.10

Finance costs

Finance costs comprise interest expense arising on intercompany balances. These costs are recognised in profit or loss using the effective interest method over the period of the financing arrangement.

1.11

Accounting Policies, Changes in Accounting Estimates and Prior period errors

Prior period errors are omissions from, and misstatements in the financial statements for one or more prior periods arising from a failure to use, or misuse of, reliable information that was available and could reasonably be expected to have been obtained and taken into account in preparing the financial statements for the periods affected. Material errors discovered in prior period figures are corrected retrospectively by amending opening balances and comparative amounts for the prior period.

 

Changes in accounting estimates are accounted for prospectively. They are applied in the current and future years affected by the change and do not give rise to a prior period adjustment. Changes in accounting policies are only made when required by proper accounting practices or the change provides more reliable or relevant information about the effect of transactions, other events and conditions on the financial position or financial performance. Where a change is made, comparative amounts for the prior period as if the new policy had always been applied.

2
Adoption of new and revised standards and changes in accounting policies

 

At the date of authorisation of these financial statements, the following Standards and Interpretations, which have not yet been applied in these financial statements, these were issued and effective but no any material impact to the company:

The following amendments are effective for the period beginning 1 January 2024:

Standards amendments in issue but not yet effective

 

The following amendments are effective for the period beginning 1 January 2025:

QUANTESSENCE TECHNOLOGY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 13 -
3
Critical accounting estimates and judgements

The preparation of the financial statements in conformity with IFRS requires the use of judgements, estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period.

 

Estimates and judgements are continually evaluated and are based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.

 

The Company makes estimates and assumptions concerning the future. The resulting accounting estimates may differ from the related actual results. The directors deem the only critical accounting estimate and judgement applied in the preparation of these financial statements to be that relating to the cost plus arrangement for the legal ringfencing fee of the intangible asset capitalised in Quantessence Financial SA.

4
Revenue
2024
2023
£
£
Fee on services rendered to Quantessence Financial SA
31,589
28,563
31,589
28,563
5
Auditor's remuneration
2024
2023
Fees payable to the Company's auditor and associates:
£
£
For audit services
- Current year
8,000
14,500
- Under provision for prior years
725
671
Audit of the financial statements of the Company
8,725
15,171
6
Employees and Directors
There were no staff costs for the year ended 31 December 2024 (2023: £Nil).
2024
2023
£
£
Directors' remuneration
-
-
QUANTESSENCE TECHNOLOGY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
(Continued)
- 14 -
7
Net finance costs
2024
2023
£
£
Interest income
Other interest income
2
-
0
Interest expense
Other interest expense
(3,061)
(1,678)
Total interest expense
(3,061)
(1,678)
Net finance costs
(3,059)
(1,678)
8
Income tax expense

The charge for the year can be reconciled to the profit/(loss) per the income statement as follows:

2024
2023
£
£
Profit/(loss) before taxation
5,108
(12,111)
Expected tax charge/(credit) based on a corporation tax rate of 19.00% (2023: 19.00%)
971
(2,301)
Unutilised tax losses carried forward
(971)
2,301
Taxation charge for the year
-
-

No liability to corporation tax arises from results in the period.

 

A deferred tax asset, at 25%, of £17,948 (2023: £19,225) have not been recognised on the basis of the

uncertainty of future taxable profit.

 

Changes in tax rates and factors affecting the future tax charges

There were no factors that may affect future tax charges.

QUANTESSENCE TECHNOLOGY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
(Continued)
- 15 -
9
Trade and other receivables
Current
Non-current
2024
2023
2024
2023
£
£
£
£
Amount owed by parent undertaking
-
0
-
0
1
1
Amounts owed by fellow group undertakings
71,627
33,987
-
0
-
0
71,627
33,987
1
1
10
Trade and other payables
2024
2023
£
£
Trade payables
4,972
10,655
Amounts owed to fellow group undertakings
105,037
60,777
Accruals
12,565
19,065
Other taxation
5,365
3,329
127,939
93,826
Amounts owed to fellow group undertakings are unsecured, interest-free and payable on demand.
11
Share capital
2024
2023
£
£
Ordinary share capital
Issued and fully paid
2 Ordinary shares of £1 each
2
2
12
Share premium account
2024
2023
£
£
At the beginning and end of the year
179,999
179,999
13
Related party transactions
Key management personnel

The key management personnel in the year ended 31 December 2024 are the directors of the business led by Peter De Clercq and Nikolaos Papadopoulos. Management does not have any post-employment benefits.

QUANTESSENCE TECHNOLOGY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
13
Related party transactions
(Continued)
- 16 -
Other transactions with related parties

During the year the Company entered into the following transactions with related parties:

 

At the year end, £71,627 (2023: £33,987) was owed by Quantessence Financial SA in respect of fee on service rendered in legal ringfencing of the groups IP less interest payable on outstanding loan amount. Interest of £266 (2023: £290) was charged on outstanding loan amount of £8,313 (2023: £8,313).

 

The Company was owed £1 (2023: £1) by Quantessence Limited in respect of unpaid share capital.

 

At the year end, £105,037 (2023: £60,777) was owed to Quantessence Financial SA. Interest of £2,795 (2023: £1,388) was charged on amounts owed to the fellow group undertakings.

 

14
Controlling party

The immediate parent unertaking is Quantessence Limited, a company incorporated in England and Wales. The ultimate parent and controlling party is Euroclear Holding SA, incorporated in Belgium. Euroclear Holding SA includes the Company in its consolidated financial statements. This is the largest and smallest Group in which the results of the Company are consolidated. The consolidated financial statements are prepared in accordance with IFRS and are available to the public and can be obtained from their website.

15
Cash generated from operations
2024
2023
£
£
Profit/(loss) for the year after tax
5,108
(12,111)
Adjustments for:
Finance costs
3,061
1,678
Finance income
(2)
-
0
Movements in working capital:
Increase in trade and other receivables
(37,906)
(33,987)
Increase in trade and other payables
31,318
50,009
Cash generated from operations
1,579
5,589
16
Events after the balance sheet date

There were no events after the balance date which require disclosure in these financial statements.

2024-12-312024-01-01falsefalseCCH SoftwareCCH Accounts Production 2025.100P De ClercqWim HautekietNikolaos Papadopoulos0097594792024-01-012024-12-3109759479bus:RegisteredOffice2024-01-012024-12-3109759479bus:Director12024-01-012024-12-31097594792024-12-3109759479core:ContinuingOperations2024-01-012024-12-31097594792023-01-012023-12-3109759479core:ContinuingOperations2023-01-012023-12-3109759479core:RetainedEarningsAccumulatedLosses2023-01-012023-12-3109759479core:RetainedEarningsAccumulatedLosses2024-01-012024-12-3109759479core:RevaluationReserve2024-01-012024-12-31097594792023-12-3109759479core:CurrentFinancialInstruments2024-12-3109759479core:CurrentFinancialInstruments2023-12-31097594792023-12-31097594792022-12-3109759479core:ShareCapital2024-12-3109759479core:ShareCapital2023-12-3109759479core:SharePremium2024-12-3109759479core:SharePremium2023-12-3109759479core:RetainedEarningsAccumulatedLosses2024-12-3109759479core:RetainedEarningsAccumulatedLosses2023-12-3109759479core:SharePremium2022-12-3109759479core:OtherMiscellaneousReserve2022-12-3109759479core:Non-currentFinancialInstruments2024-12-3109759479core:Non-currentFinancialInstruments2023-12-3109759479bus:OrdinaryShareClass12024-01-012024-12-3109759479bus:PrivateLimitedCompanyLtd2024-01-012024-12-3109759479bus:Audited2024-01-012024-12-3109759479bus:FullIFRS2024-01-012024-12-3109759479bus:Director22024-01-012024-12-3109759479bus:Director32024-01-012024-12-3109759479bus:FullAccounts2024-01-012024-12-31xbrli:purexbrli:sharesiso4217:GBP